Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3133369
Max Phase: Preclinical
Molecular Formula: C53H66N14O12
Molecular Weight: 1091.20
Molecule Type: Unknown
Associated Items:
ID: ALA3133369
Max Phase: Preclinical
Molecular Formula: C53H66N14O12
Molecular Weight: 1091.20
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC[C@H](C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(C)=O)C/C=C/C[C@@H](C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(N)=O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CCC(=O)O)NC1=O
Standard InChI: InChI=1S/C53H66N14O12/c1-4-28(2)45-53(79)63-39(17-18-44(70)71)48(74)65-43(22-33-25-56-27-59-33)52(78)66-42(21-32-24-55-26-58-32)51(77)61-37(47(73)64-40(46(54)72)20-31-23-57-36-10-6-5-9-35(31)36)11-7-8-12-38(49(75)67-45)62-50(76)41(60-29(3)68)19-30-13-15-34(69)16-14-30/h5-10,13-16,23-28,37-43,45,57,69H,4,11-12,17-22H2,1-3H3,(H2,54,72)(H,55,58)(H,56,59)(H,60,68)(H,61,77)(H,62,76)(H,63,79)(H,64,73)(H,65,74)(H,66,78)(H,67,75)(H,70,71)/b8-7+/t28-,37-,38-,39-,40-,41-,42-,43-,45-/m0/s1
Standard InChI Key: LFUAEEPNMZRROQ-GZBWWYMSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1091.20 | Molecular Weight (Monoisotopic): 1090.4985 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Meinander K, Weisell J, Pakkala M, Tadd AC, Hekim C, Kallionpaa R, Widell K, Stenman U, Koistinen H, Narvanen A, Vepsalainen J, Luthman K, Wallen EAA. (2013) Pseudopeptides with a centrally positioned alkene-based disulphide bridge mimetic stimulate kallikrein-related peptidase 3 activity, 4 (3): [10.1039/C3MD20292E] |
Source(1):